Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000904454-20-000428
Filing Date
2020-07-06
Accepted
2020-07-02 18:21:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G FOR FUSION PHARMACEUTICALS INC. BY JOHNSON & JOHNSON s13g_063020-fusion.htm SC 13G 52029
  Complete submission text file 0000904454-20-000428.txt   53574
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Subject) CIK: 0001805890 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91552 | Film No.: 201011350
SIC: 2836 Biological Products, (No Diagnostic Substances)